Ginkgo Bioworks Holdings (DNA) Net Income towards Common Stockholders Growth (1y) (2021 - 2026)
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) Net Income towards Common Stockholders Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.38 Bn | 40.30 Bn | 1.44 Bn | -9.74% |
| 2 | Medpace Holdings | 16.51 Bn | 16.01 Bn | 201.64 Mn | 34.46% |
| 3 | Charles River Laboratories International | 13.16 Bn | 12.97 Bn | 452.07 Mn | -101.45% |
| 4 | Icon | 12.39 Bn | 11.46 Bn | 479.29 Mn | -29.22% |
| 5 | Fortrea Holdings | 1.57 Bn | 1.40 Bn | 139.20 Mn | 96.48% |
| 6 | Evotec SE | 621.88 Mn | 196.00 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 419.14 Mn | 334.60 Mn | 18.44 Mn | 22.54% |
| 8 | Champions Oncology | 71.79 Mn | 71.79 Mn | 7.03 Mn | 63.65% |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 81.16% |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.54% |
| Mar 31, 2026 | 9.20% |
| Dec 31, 2025 | 24.91% |
| Sep 30, 2025 | -43.18% |
| Jun 30, 2025 | 72.24% |
| Mar 31, 2025 | 45.18% |
| Dec 31, 2024 | 49.20% |
| Sep 30, 2024 | 81.38% |
| Jun 30, 2024 | -25.31% |
| Mar 31, 2024 | 19.06% |
| Dec 31, 2023 | -22.31% |
| Sep 30, 2023 | 54.80% |
| Jun 30, 2023 | 74.15% |
| Mar 31, 2023 | 65.29% |
| Dec 31, 2022 | 89.22% |
| Sep 30, 2022 | -554.39% |
| Jun 30, 2022 | -1,131.22% |
| Mar 31, 2022 | -689.68% |
| Dec 31, 2021 | -3,359.12% |
| Sep 30, 2021 | -291.97% |